We are live on
!
Find out more
SEI Investments Portfolio holdings
AUM
$108B
1-Year Est. Return
26.14%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+26.14%
3 Year Est. Return
+80.41%
5 Year Est. Return
+95.44%
10 Year Est. Return
+382.16%
AUM
$53.8B
AUM Growth
+$8.84B
(+20%)
Cap. Flow
+$5.86B
Cap. Flow
% of AUM
10.88%
Top 10 Holdings %
Top 10 Hldgs %
16.61%
Holding
2,791
New
278
Increased
1,697
Reduced
572
Closed
114
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$179M |
| 2 |
Microsoft
MSFT
|
+$178M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$141M |
| 4 |
Amazon
AMZN
|
+$127M |
| 5 |
Linde
LIN
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$73.4M |
| 2 |
SLB Ltd
SLB
|
+$72.2M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$55M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$53.1M |
| 5 |
Adobe
ADBE
|
+$44.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.6% |
| 2 | Healthcare | 11.41% |
| 3 | Financials | 9.03% |
| 4 | Consumer Discretionary | 8.81% |
| 5 | Industrials | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MREO
2526
Mereo BioPharma
MREO
$50.4M
| $41.5K | ﹤0.01% |
+58,718
| New | +$52.8K |
|
|
DHC
2527
Diversified Healthcare Trust
DHC
$2.13B
| $40.5K | ﹤0.01% |
+30,031
| New | +$31K |
|
|
SNCR
2528
DELISTED
Synchronoss Technologies
SNCR
| $39.8K | ﹤0.01% |
+4,706
| New | +$37.8K |
|
2529
C4 Therapeutics
CCCC
$387M
| $38.2K | ﹤0.01% |
12,152
+917
| +8% | +$5.4K |
|
2530
FuelCell Energy
FCEL
$1.71B
| $33.5K | ﹤0.01% |
+392
| New | +$38.6K |
|
|
ESPR
2531
DELISTED
Esperion Therapeutics
ESPR
| $33.4K | ﹤0.01% |
20,979
+9,242
| +79% | +$47.7K |
|
|
NBIS
2532
Nebius Group N.V.
NBIS
$54B
| $30.3K | ﹤0.01% |
338,619
+128,652
| +61% | +$11.5K |
|
|
AFMD
2533
DELISTED
Affimed
AFMD
| $29.4K | ﹤0.01% |
3,942
-242
| -6% | -$2.42K |
|
|
AGEN
2534
Agenus
AGEN
$326M
| $28K | ﹤0.01% |
+938
| New | +$39.6K |
|
2535
Heron Therapeutics
HRTX
$96.8M
| $27.4K | ﹤0.01% |
+18,138
| New | +$45.4K |
|
2536
Opendoor
OPEN
$3.8B
| $27.2K | ﹤0.01% |
+15,959
| New | +$26.3K |
|
2537
Amneal Pharmaceuticals
AMRX
$6.02B
| $26.7K | ﹤0.01% |
19,166
+2,572
| +15% | +$5.12K |
|
|
IRS.WS
2538
DELISTED
IRSA Inversiones y Representaciones S.A. Warrants
IRS.WS
| $26.6K | ﹤0.01% |
88,610
| – | – |
|
|
DM
2539
DELISTED
Desktop Metal, Inc.
DM
| $24.3K | ﹤0.01% |
+1,057
| New | +$20K |
|
|
DOYU
2540
DouYu International Holdings
DOYU
$142M
| $22.3K | ﹤0.01% |
+1,877
| New | +$27.8K |
|
|
NUTX
2541
Nutex Health
NUTX
$1.05B
| $21.3K | ﹤0.01% |
+141
| New | +$28.6K |
|
2542
Globalstar
GSAT
$10.8B
| $20.5K | ﹤0.01% |
+1,180
| New | +$21.7K |
|
|
EQRX
2543
DELISTED
EQRx, Inc. Common Stock
EQRX
| $20.1K | ﹤0.01% |
+10,335
| New | +$23.5K |
|
2544
Nektar Therapeutics
NKTR
$2.38B
| $19.3K | ﹤0.01% |
1,830
+296
| +19% | +$8.96K |
|
|
TELL
2545
DELISTED
Tellurian Inc.
TELL
| $16.5K | ﹤0.01% |
+13,415
| New | +$21.4K |
|
2546
Opko Health
OPK
$978M
| $14.8K | ﹤0.01% |
+10,163
| New | +$13.1K |
|
|
EMKR
2547
DELISTED
Emcore Corp
EMKR
| $12.3K | ﹤0.01% |
1,077
-1,347
| -56% | -$16.4K |
|
2548
Outlook Therapeutics
OTLK
$171M
| $11.5K | ﹤0.01% |
+527
| New | +$11.8K |
|
|
CTEV
2549
Claritev Corp
CTEV
$414M
| $11.3K | ﹤0.01% |
+266
| New | +$12K |
|
2550
a.k.a. Brands
AKA
$124M
| $10.8K | ﹤0.01% |
1,647
-394
| -19% | -$5.97K |
|
Similar funds
SEI Investments's Q1 2023 Portfolio in Review
As of Q1 2023, SEI Investments held 2,791 positions worth $53.8B, up 20% from $45B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
SEI Investments deployed $5.86B of net new capital in Q1 2023, opening 278 new positions and adding to 1,697 existing holdings. Its largest new stake was GE HealthCare: 189,301 shares worth $15.5M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Charles Schwab, an estimated $73.4M trimmed.
- SEI Investments's largest Q1 2023 buy was GE HealthCare: 189,301 shares worth $15.5M.
- SEI Investments added most to Apple in Q1 2023, an estimated $179M increase.
- SEI Investments's biggest Q1 2023 reduction was Charles Schwab, cutting an estimated $73.4M.
- SEI Investments fully exited SVB Financial Group in Q1 2023, selling an estimated $55M.
- SEI Investments's ten largest holdings make up 17% of its $53.8B portfolio in Q1 2023.
- SEI Investments opened 278 new positions and closed 114 in Q1 2023.
- SEI Investments's portfolio value rose 20% quarter-over-quarter to $53.8B.
Based on SEI Investments's 13F filing for Q1 2023, filed 12 May 2023.